Loading
The molecular landscape: the targets and how often each appears, the pathways, the mechanics stages and the preclinical models.
The targets of this cancer's medicines and the ones linked to it directly.
| Target / alteration | Prevalence | Measure | Source |
|---|---|---|---|
| Glypican-3 | 70-80% | IHC, any expression | Wikipedia |
| VEGF / VEGFR | n/a | Angiogenic dependency; no selection biomarker | Wikipedia |
How common each drug target or alteration is in this cancer. Population-level and approximate; see the target page for detail. Full matrix.
6 cell lines, 1 mouse models and 6 repositories are listed for this cancer. See them →